rently unknown whether the DNA lesions associated with CSR and SHM induce H2B
Ser14P
.
In this study, we analyze, by chromatin immunoprecipitation (ChIP), chromatin modifications on both heavy and light chain Ig loci during SHM in vivo. We find that histone acetylation, H3-K4 methylation, and DNA methylation of the V region are similar in naive and GC B cells. Additionally, although V H is hyperacetylated as compared to C , in the Igλ locus we detect no difference in histone acetylation or H3-K4 methylation between the V and C regions. We conclude that dynamic alterations of these chromatin modifications do not accompany the activation of SHM in vivo and that histone acetylation and H3-K4 methylation do not by themselves confer targeting of SHM specifically to V regions within Ig loci. Our data further suggest that γH2AX is associated with CSR but not SHM in vivo and hence that aspects of the DNA lesions introduced during CSR and SHM differ. Finally, we identify a novel chromatin marker for hypermutating V regions, H2B
, and find that H2B
Ser14P is associated with S in GC B cells as well. Phosphorylation of H2B is tightly correlated with the recruitment of Mst1 at both the V and S regions. Thus, a novel pattern of histone modifications (H2B Ser14P in the absence of γH2AX) is associated with SHM in primary B cells. cells was subject to SHM. To this end, we PCR amplified, cloned, and sequenced the rearranged VJλ1 and was not due to nonspecific immunoprecipitation as the β-globin gene, which should be hypoacetylated in Histone and DNA Modifications at the Ig Locus these cells, was barely detectable in the IP samples. in Naive and GC B Cells Second, we did not observe any significant difference We used chromatin immunoprecipitation (ChIP) to meain levels of acetylation for any of the Igλ regions tested sure the levels of H3 and H4 acetylation as well as H3-when comparing naive, day 10 GC, and day 14 GC B K4 methylation at four sites in the Igλ locus: two recells ( Figures 2B and 2C ). This indicates that the transigions of VJλ, Cλ, and the enhancer responsible for tion from a nonmutating, naive B cell to a mutating, GC driving transcription of Vλ1, Eλ3-1 (Figure 2A) . GC B B cell is not accompanied by a change in histone acetycells were purified at two different time points during lation at VJλ1, Cλ1, or Eλ3-1 and that levels of histone the germinal center reaction, day 10 and day 14 postimacetylation are maintained during the peak of the GC munization, and naive B cells were collected from the response. To show that we can detect changes in hisspleens of unimmunized mice. Input (prior to immunotone acetylation on genes differentially regulated in naprecipitation) and immunoprecipitated samples were ive and GC B cells, we examined the histone acetylaanalyzed by Taqman We began by analyzing VJλ1 from day 10 and day 14 GC B cells isolated from immunized B1-8(Tg) mice. We were unable to detect γH2AX at VJλ1, Cλ, Eλ3-1, or at mb1 in day 10 or day 14 GC B cells (Figures 5A and  5B ). In the same sorted cells, however, γH2AX was associated with the S region in GC but not naive B cells, as expected (Figures 5A and 5B ). Since it is not known if H2AX is evenly distributed throughout the genome, we analyzed the association of H2AX at VJλ1 and S in GC B cells (using an antibody that binds H2AX regardless of its phosphorylation state) and detected equivalent levels of H2AX at these regions (data not shown). Our inability to detect γH2AX at VJλ1 is therefore not simply a consequence of an absence of the H2AX histone at this region. We note that the region of the S and E probe sites, which are immediately adjacent to one another ( Figure 4A ), while lower levels were observed at the more distal V H (KI) and C regions (Fig-5C) . Thus, γH2AX can be detected at the V region of IgH, a locus where both CSR and SHM occur, and not ure 5C). As expected, in naive B cells we could not detect γH2AX anywhere on the IgH locus (Figures 5B and at Vλ, where only SHM occurs. This suggests that Figure 6A ). been implicated; in the latter case, the pathway leading to H2B Ser14P is unknown. We wanted to determine We then examined H2B Ser14P levels at the IgH locus in splenic B cells from B1-8(KI) mice. H2B Ser14P was not whether H2B Ser14P is a marker for regions actively undergoing SHM and CSR. Naive, day 10, and day 14 GC associated with the V H (KI) or S regions in naive or day 14 GC B cells but was reproducibly detected at both B cells were isolated from B1-8(Tg) mice and the presence of H2B Ser14P at Igλ was investigated by ChIP. Alregions in day 10 GC B cells, at levels 4-to 7-fold higher than in naive B cells ( Figure 6C ). H2B Ser14P was not dethough H2B Ser14P was not associated with VJλ1 in naive B cells, it was reproducibly detected at both site 2 (Figtected at E or C at any time point, suggesting that unlike γH2AX, this modification does not spread from ure 6A) and site 1 (Figure 6B) and 6B) . Thus, the phosphorylation of H2B at Igλ and S is dependent upon AID.
Results

Isolation and Characterization of NP-Specific
Since Mst1 is the only known kinase of H2B, we used ChIP to determine whether Mst1 might be found in association with the same Ig DNA regions that accumulate H2B Ser14P in response to SHM and CSR. Due to a significant degree of variability in the detection of Mst1 by ChIP, the complete data set is presented as scatter plots. Strikingly, Mst1 was detected at VJλ1 and S but not the mb1 promoter, Cλ, Eλ3-1, or β-globin in day 10 Figures  7A-7C) . Additionally, Mst1 was not observed at Vλ, V H or S at day 14 postimmunization (data not shown), in keeping with the reduced levels of H2B Ser14P seen at this time point. Based on these data and the known function of Mst1 as a kinase of H2B, we propose that Mst1 phosphorylates H2B in response to an AID-initiated event in both SHM and CSR. Table S1 . 
GC B cells from immunized B1-8(Tg) mice (Figures 7A and 7B). Similarly, Mst1 was detectable in day 10 GC B cells on both V H (KI) and S in the B1-8(KI) mice (Figure 7C). In naive B cells, however, Mst1 was not detectable at any region analyzed, including Vλ, V H or S (
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